Diabetes: Device checks saliva, not blood

Key points
- A new technique to measure glucose in saliva could eliminate the need for diabetics to draw blood to check blood sugar levels.
- The biochip developed by engineers at Brown University uses plasmonic interferometers and could be employed to measure a range of biological and environmental substances.
- The technique takes advantage of a convergence of nanotechnology and surface plasmonics, which explores the interaction of electrons and photons (light).
- Their results, reported in the journal Nano Letters, show that the specially designed biochip could detect glucose levels similar to the levels found in human saliva.
A new technique to measure glucose in saliva could eliminate the need for diabetics to draw blood to check blood sugar levels.
The biochip developed by engineers at Brown University uses plasmonic interferometers and could be employed to measure a range of biological and environmental substances.
The technique takes advantage of a convergence of nanotechnology and surface plasmonics, which explores the interaction of electrons and photons (light). The engineers etched thousands of plasmonic interferometers onto a fingernail-size biochip and measured the concentration of glucose molecules in water on the chip.
Their results, reported in the journal Nano Letters, show that the specially designed biochip could detect glucose levels similar to the levels found in human saliva. Glucose in human saliva is typically about 100 times less concentrated than in the blood.
“This is proof of concept that plasmonic interferometers can be used to detect molecules in low concentrations, using a footprint that is ten times smaller than a human hair,” says Domenico Pacifici, assistant professor of engineering and lead author of the paper.
The technique can be used to detect other chemicals or substances, from anthrax to biological compounds, Pacifici says, “and to detect them all at once, in parallel, using the same chip.”
To create the sensor, the researchers carved a slit about 100 nanometers wide and etched two 200 nanometer-wide grooves on either side of the slit. The slit captures incoming photons and confines them. The grooves, meanwhile, scatter the incoming photons, which interact with the free electrons bounding around on the sensor’s metal surface.
Those free electron-photon interactions create a surface plasmon polariton, a special wave with a wavelength that is narrower than a photon in free space. These surface plasmon waves move along the sensor’s surface until they encounter the photons in the slit, much like two ocean waves coming from different directions and colliding with each other.
This “interference” between the two waves determines maxima and minima in the light intensity transmitted through the slit. The presence of an analyte (the chemical being measured) on the sensor surface generates a change in the relative phase difference between the two surface plasmon waves, which in turns causes a change in light intensity, measured by the researchers in real time.
“The slit is acting as a mixer for the three beams—the incident light and the surface plasmon waves,” Pacifici said.
The engineers learned they could vary the phase shift for an interferometer by changing the distance between the grooves and the slit, meaning they could tune the interference generated by the waves.
The researchers could tune the thousands of interferometers to establish baselines, which could then be used to accurately measure concentrations of glucose in water as low as 0.36 milligrams per deciliter.
Written and revised by
Andrey Nailor, M.D.
Our doctors write and review articles for accuracy and keep them up to date.
health.am provides general information, not medical advice. Always consult a qualified health professional about your own health.
Explore health topics
More in this topic
Diabetes & Hormones →
NewsConvenient blood test not as effective for diagnosing diabetes in children
Doctors are increasingly using a convenient blood glucose test for diagnosing diabetes and pre-diabetes, but a study by the University of Michigan's C.S. Mott Children's Hospital shows it's not the best way to diagnose…
24 February 2011
NewsResearchers Discover Root Cause of Blood Vessel Damage in Diabetes
A key mechanism that appears to contribute to blood vessel damage in people with diabetes has been identified by researchers at Washington University School of Medicine in St. Louis. Blood vessel problems are a common…
31 January 2011
NewsFDA rejects MannKind diabetes device, shares dive
MannKind Corp said on Wednesday that U.S. regulators rejected Afrezza, its experimental device to treat diabetes, and have asked for two more clinical trials. MannKind's shares fell 43 percent to $5.15 in afterhours…




